New all-in-one IVT kit can deliver up to 2X more mRNA and up to 85% lower dsRNA compared to other kits on the market through streamlined mRNA synthesis with efficient capping, increased yield, reduced ...
Leveraging its integrated “design-synthesis-quality control” system, Creative Biolabs is overcoming bottlenecks in mRNA drug expression and in vivo stability ...
The Australia mRNA therapeutics market offers significant growth potential, driven by government support, technological ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results